LUNG Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own LUNG shares is 165, representing 93.43% of the company's common stock.

GOLDMAN SACHS GROUP INC, in the last quarter, reduced its stake in LUNG by -14.98% restricting it's holding to 214.61 thousand shares of worth nearly $1.99M. DIVISADERO STREET CAPITAL MANAGEMENT, LP also lessened -85.18% of the LUNG shares from its portfolio, reducing its holding to 208.47 thousand shares of worth $1.93M. JACOBS LEVY EQUITY MANAGEMENT, INC also shunned LUNG shares holding by -45.9% last quarter which brought its holding to 197.34 thousand shares worth $1.83M.

As per its latest 13F filing, JPMORGAN CHASE & CO increased its stake in LUNG by 406.24% in the last quarter. The institutional holder raised its holding to 264.58 thousand shares having worth more than $2.45M. ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC also added 609.67% more shares of LUNG to its portfolio, raising its holding to 8.52 thousand shares of worth $78.94K. MILLRACE ASSET GROUP, INC. also increased its LUNG shares holding by 100% which brought its holding to 191.58 thousand shares worth $1.78M.

The insider with the most stakes in LUNG is French Glendon E. III , director at the company. Additionally, LUNG stock is highly held by Chief Financial Officer Sung Derrick and CHIEF COMMERCIAL OFFICER Rose Geoffrey Beran among others.

Company executives, directors, and other insiders own 4.98% percent of Pulmonx Corporation's stock. Within the last six months, there have been 9 transaction(s) in which LUNG insiders have sold stock, totaling 70.99K shares. Insiders that have sold shares include FRENCH GLENDON E. III, ROSE GEOFFREY BERAN, and LEHMAN DAVID AARON.

There have been 0 transaction(s) during the past 6-months in which Pulmonx Corporation insiders have bought stock, totalling 0 shares

Around 6.4M Pulmonx Corporation shares are held by insiders, which represents about 4.98% of LUNG stock.

LUNG director, French Glendon E. III holds the largest portfolio of the company's shares. LUNG shares owned by French total nearly 1.07 million.

JPMORGAN CHASE & CO is the largest institutional owner in LUNG which holds 264.58 thousand shares worth $2.45M or 0.69% of the total LUNG shares outstanding followed by ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC with ownership of 8.52 thousand shares representing 0.02% of the LUNG ownership. GOLDMAN SACHS GROUP INC is the third largest stakeholder with 214.61 thousand shares or 0.56% of the ownership worth more than $1.99M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the LUNG is concerned, it is a stock which is optionable.

Number of LUNG shares short is 1.25M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 39.49M shares of LUNG are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, LUNG has 37.82M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for LUNG is 5.29.